Science Advances · 2022 · 14 citations · 37 references
Life SciencesMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingCell Signaling NetworksInnate Immune Signaling PathwaysInterferon ResponsesSignal Transduction In CancerSignal Transduction PathwaysCancer Signaling PathwaysInterferon Signaling ModulationMolecular Drug ResistanceSignalsTumor Cell Survival Pathways
Cancer persister cells are able to survive otherwise lethal doses of drugs through nongenetic mechanisms, which can lead to cancer regrowth and drug resistance. The broad spectrum of molecular differences observed between persisters and their treatment-naïve counterparts makes it challenging to identify causal mechanisms underlying persistence. Here, we modulate environmental signals to identify cellular mechanisms that promote the emergence of persisters and to pinpoint actionable vulnerabilities that eliminate them. We found that interferon-γ (IFNγ) can induce a pro-persistence signal that can be specifically eliminated by inhibition of type I protein arginine methyltransferase (PRMT) (PRMTi). Mechanistic investigation revealed that signal transducer and activator of transcription 1 (STAT1) is a key component connecting IFNγ's pro-persistence and PRMTi's antipersistence effects, suggesting a previously unknown application of PRMTi to target persisters in settings with high STAT1 expression. Modulating environmental signals can accelerate the identification of mechanisms that promote and eliminate cancer persistence.
37
Bacterial Persistence as a Phenotypic Switch
Nathalie Q. Balaban, Jack Merrin, Remy Chait et al. · Science · 2004 · 3K citations
Life Sciences, Biology, Microbiology +16
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma, Diana Lee, Bihua Li et al. · Cell · 2010 · 2.8K citations · Full text
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen, Yanjiao Li, Tzong‐Shiue Yu et al. · Nature · 2012 · 2.3K citations
Medicine, Cancer Biology, Oncology +14
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer, Vasanthi S. Viswanathan, Matthew J. Ryan et al. · Nature · 2017 · 1.7K citations
Medicine, Oncology, Pharmacology +11